Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Anti-MG7 chimeric antigen receptor T cell therapy - Shanghai Genechem

Next Previous
Drug Profile

Anti-MG7 chimeric antigen receptor T cell therapy - Shanghai Genechem

Alternative Names: Anti-MG7 CAR-T cell-therapy; Anti-MG7 CAR-T cells; MG7 CAR-T-cells; MG7 chimeric antigen receptor T cells; MG7-targeted chimeric antigen receptor T cells

Latest Information Update: 18 Feb 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shanghai Genechem
  • Developer Shanghai Genechem; Xijing Hospital
  • Class CAR-T cell therapies; Gene therapies; Immunotherapies
  • Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Liver metastases

Most Recent Events

  • 18 Feb 2022 Discontinued - Phase-I/II for Liver metastases in China (Intratumoural)
  • 01 Jun 2016 Phase-I/II clinical trials in Liver metastases (In adults) in China (Intratumoural) (NCT02862704)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top